JP2019531279A5 - - Google Patents

Download PDF

Info

Publication number
JP2019531279A5
JP2019531279A5 JP2019512859A JP2019512859A JP2019531279A5 JP 2019531279 A5 JP2019531279 A5 JP 2019531279A5 JP 2019512859 A JP2019512859 A JP 2019512859A JP 2019512859 A JP2019512859 A JP 2019512859A JP 2019531279 A5 JP2019531279 A5 JP 2019531279A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
solvate
acceptable salt
compound according
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019512859A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019531279A (ja
JP7042804B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/052106 external-priority patent/WO2018053447A1/en
Publication of JP2019531279A publication Critical patent/JP2019531279A/ja
Publication of JP2019531279A5 publication Critical patent/JP2019531279A5/ja
Application granted granted Critical
Publication of JP7042804B2 publication Critical patent/JP7042804B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019512859A 2016-09-19 2017-09-18 ピペラジンカルバメート、及びその製造と使用の方法 Active JP7042804B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662396561P 2016-09-19 2016-09-19
US62/396,561 2016-09-19
PCT/US2017/052106 WO2018053447A1 (en) 2016-09-19 2017-09-18 Piperazine carbamates and methods of making and using same

Publications (3)

Publication Number Publication Date
JP2019531279A JP2019531279A (ja) 2019-10-31
JP2019531279A5 true JP2019531279A5 (OSRAM) 2020-11-05
JP7042804B2 JP7042804B2 (ja) 2022-03-28

Family

ID=61619083

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019512859A Active JP7042804B2 (ja) 2016-09-19 2017-09-18 ピペラジンカルバメート、及びその製造と使用の方法

Country Status (6)

Country Link
US (1) US10899737B2 (OSRAM)
EP (1) EP3515897B1 (OSRAM)
JP (1) JP7042804B2 (OSRAM)
CN (1) CN109996790B (OSRAM)
ES (1) ES2892952T3 (OSRAM)
WO (1) WO2018053447A1 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ627750A (en) 2012-01-06 2016-11-25 Abide Therapeutics Inc Carbamate compounds and of making and using same
WO2017143283A1 (en) 2016-02-19 2017-08-24 Abide Therapeutics, Inc. Radiolabeled monoacylglycerol lipase occupancy probe
US10899737B2 (en) 2016-09-19 2021-01-26 Lundbeck La Jolla Research Center, Inc. Piperazine carbamates and methods of making and using same
JOP20190106A1 (ar) * 2016-11-16 2019-05-09 Lundbeck La Jolla Research Center Inc مثبطات أحادي أسيل جليسرول ليباز (magl)
JOP20180009A1 (ar) 2017-02-06 2019-01-30 Gilead Sciences Inc مركبات مثبط فيروس hiv
KR20210010475A (ko) 2018-05-15 2021-01-27 룬드벡 라 졸라 리서치 센터 인코포레이티드 Magl 저해제
KR20210033504A (ko) * 2018-07-19 2021-03-26 화이자 인코포레이티드 Magl 억제제로서 헤테로환형 스피로 화합물
US20220387411A1 (en) * 2019-09-25 2022-12-08 Frontier Medicines Corporation Targeted autophagy conjugates and methods
CN114761382A (zh) * 2019-11-15 2022-07-15 H.隆德贝克有限公司 Magl抑制剂的晶型
KR20230004622A (ko) * 2020-04-21 2023-01-06 하. 룬드벡 아크티에셀스카브 모노아실글리세롤 리파제 억제제의 합성
US20250084065A1 (en) 2021-12-29 2025-03-13 Psy Therapeutics, Inc. Inhibiting monoacylglycerol lipase (magl)
WO2024168426A1 (en) 2023-02-13 2024-08-22 Apogee Pharmaceuticals, Inc. Small molecules as monoacylglycerol lipase (magl) inhibitors, compositions and use thereof

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1009363A (en) 1911-07-05 1911-11-21 Albert Winnie Artificial fishing-bait.
US1057010A (en) 1913-01-14 1913-03-25 Harry L Roderick Means for controlling doors and steps of cars.
FR1593586A (OSRAM) 1967-10-17 1970-06-01
JPS6183073A (ja) 1984-10-01 1986-04-26 Oki Electric Ind Co Ltd 印字装置の用紙送り方法
WO1989011794A1 (fr) 1988-06-07 1989-12-14 Rikagaku Kenkyusho Inhibiteur de la croissance de plantes
EP0619804B1 (en) 1991-11-27 1996-05-22 E.I. Du Pont De Nemours And Company Herbicidal acylated amino-(phenyl- or pyridinyl- or thienyl-)-phenyl derivatives
EP0736047B1 (en) 1993-12-22 1998-03-04 Shell Internationale Researchmaatschappij B.V. Process for preparing carbamates
AU7579696A (en) 1995-11-15 1997-06-05 Zeneca Limited Herbicidal substituted pyrazole compounds
AU3440597A (en) 1996-07-02 1998-01-21 Novartis Ag N-phenylimino heterocyclic derivatives and their use as herbicides
RU2167150C2 (ru) 1998-03-25 2001-05-20 Фокин Александр Васильевич Полифторалкил-n-арилкарбаматы, обладающие антимикробной активностью
AU7856600A (en) 1999-10-04 2001-05-10 University Of Medicine And Dentistry Of New Jersey Novel carbamates and ureas
EP1201298A1 (en) 2000-10-24 2002-05-02 Urea Casale S.A. Carbamate condensation unit
DE10348022A1 (de) 2003-10-15 2005-05-25 Imtm Gmbh Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
FR2864080B1 (fr) 2003-12-23 2006-02-03 Sanofi Synthelabo Derives de 1-piperazine-et-1-homopiperazine-carboxylates, leur preparation et leur application en therapeutique
WO2005063698A1 (en) 2003-12-31 2005-07-14 Council Of Scientific & Industrial Research Process for preparing carbamates
RU2006128445A (ru) 2004-02-18 2008-03-27 Астразенека Аб (Se) Ацетилиновые пиперазиновые соединения и их применение в качестве антагонистов метаботропных глутаматных рецепторов
US7786113B2 (en) 2004-12-23 2010-08-31 Hoffman-La Roche Inc. Heterocyclic carbamate derivatives, their manufacture and use as pharmaceutical agents
BRPI0519343A2 (pt) 2004-12-30 2009-01-20 Janssen Pharmaceutica Nv piperazinil e piperidinil urÉias e compostos relacionados como moduladores de hidrolase de amida de Ácido graxo para o tratamento de ansiedade, dor e outras condiÇÕes
JP2009523729A (ja) 2006-01-13 2009-06-25 ピーティーシー セラピューティクス,インコーポレーテッド C型肝炎の治療方法
HRP20150642T1 (hr) 2006-12-22 2015-08-14 Astex Therapeutics Limited BICIKLIÄŚKE HETEROCIKLIÄŚKE TVARI KAO INHIBITORI FGFR-a
WO2008106047A2 (en) 2007-02-26 2008-09-04 Kosan Biosciences Incorporated Carbamate compounds
US8188098B2 (en) 2008-05-19 2012-05-29 Hoffmann-La Roche Inc. GPR119 receptor agonists
EP2328897A1 (en) 2008-07-16 2011-06-08 Schering Corporation Bicyclic heterocycle derivatives and their use as gpcr modulators
US8772318B2 (en) 2008-11-14 2014-07-08 The Scripps Research Institute Methods and compositions related to targeting monoacylglycerol lipase
EP2411010B1 (en) 2009-03-23 2013-11-06 Msd K.K. Novel aminopyridine derivatives having aurora a selective inhibitory action
UA107791C2 (en) 2009-05-05 2015-02-25 Dow Agrosciences Llc Pesticidal compositions
EP2497082B1 (de) 2009-11-03 2013-09-04 Bayer Intellectual Property GmbH Fluorurethane als additive in einer photopolymer-formulierung
FR2960875B1 (fr) 2010-06-04 2012-12-28 Sanofi Aventis Derives de carbamates d'hexafluoroisopropyle, leur preparation et leur application en therapeutique
ES2675760T3 (es) 2012-01-06 2018-07-12 Agios Pharmaceuticals, Inc. Compuestos terapéuticamente activos y métodos de uso de los mismos
NZ627750A (en) * 2012-01-06 2016-11-25 Abide Therapeutics Inc Carbamate compounds and of making and using same
CA2866302A1 (en) 2012-03-19 2013-09-26 Abide Therapeutics, Inc. Carbamate compounds and of making and using same
US9551036B2 (en) 2013-02-25 2017-01-24 Whitehead Institute For Biomedical Research Metabolic gene mesenchymal signatures and uses thereof
US9828379B2 (en) * 2013-07-03 2017-11-28 Abide Therapeutics, Inc. Pyrrolo-pyrrole carbamate and related organic compounds, pharmaceutical compositions, and medical uses thereof
WO2016014975A2 (en) 2014-07-25 2016-01-28 Northeastern University Urea/carbamates faah magl or dual faah/magl inhibitors and uses thereof
WO2016149401A2 (en) 2015-03-18 2016-09-22 Abide Therapeutics, Inc. Piperazine carbamates and methods of making and using same
US10899737B2 (en) 2016-09-19 2021-01-26 Lundbeck La Jolla Research Center, Inc. Piperazine carbamates and methods of making and using same
JOP20190106A1 (ar) 2016-11-16 2019-05-09 Lundbeck La Jolla Research Center Inc مثبطات أحادي أسيل جليسرول ليباز (magl)
HUE064559T2 (hu) 2016-11-16 2024-03-28 H Lundbeck As MAGL inhibitor kristályos formája
JOP20190105A1 (ar) 2016-11-16 2019-05-09 Lundbeck La Jolla Research Center Inc مثبطات أحادي أسيل جليسرول ليباز (magl)
BR112020003946A2 (pt) 2017-08-29 2020-09-08 Lundbeck La Jolla Research Center, Inc. compostos de espirociclo e métodos para produzir e usar os mesmos
KR20210010475A (ko) 2018-05-15 2021-01-27 룬드벡 라 졸라 리서치 센터 인코포레이티드 Magl 저해제

Similar Documents

Publication Publication Date Title
JP2019531279A5 (OSRAM)
JP2018529650A5 (OSRAM)
JP2019524883A5 (OSRAM)
JP2020530487A5 (OSRAM)
JP2020532547A5 (OSRAM)
JP2019034943A5 (OSRAM)
JP2020502047A5 (OSRAM)
JP2014511891A5 (OSRAM)
JP2020532545A5 (OSRAM)
JP2016121196A5 (OSRAM)
JP2020529994A5 (OSRAM)
JP2018519323A5 (OSRAM)
JP2019535672A5 (OSRAM)
JP2017538689A5 (OSRAM)
JP2014015465A5 (OSRAM)
JP2017530959A5 (OSRAM)
JP2014193925A5 (OSRAM)
JP2014507455A5 (OSRAM)
JP2009542595A5 (OSRAM)
JP2017523225A5 (OSRAM)
JP2020521767A5 (OSRAM)
JP2015520140A5 (OSRAM)
JP2016525130A5 (OSRAM)
JP2020521766A5 (OSRAM)
JP2016531126A5 (OSRAM)